Skip to main content
Addgene

GluCl.CreON enables selective inhibition of molecularly defined pain circuits.

Middleton SJ, Hu H, Perez-Sanchez J, Zuberi S, McGrath Williams J, Weir GA, Bennett DL
Pain. 2023 Jun 27. doi: 10.1097/j.pain.0000000000002976. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
196995pAAV-sCAG-GluClα.CreONCre recombinase dependent expression of GluClv2.0 alpha subunit. GluClα contains a Cerulean tag. When co-expressed with GluClv2.0 beta subunit, agonist (Ivermectin) induces neuronal silencing.
196996pAAV-sCAG-GluClβ.CreONCre recombinase dependent expression of GluClv2.0 beta subunit. GluClβ contains a YFP tag. When co-expressed with GluClv2.0 alpha subunit, agonist (Ivermectin) induces neuronal silencing.

Antibodies from Article